Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. [electronic resource]
Producer: 20011025Description: 678-83 p. digitalISSN:- 1524-4571
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Animals
- Antihypertensive Agents -- pharmacology
- Blood Flow Velocity -- drug effects
- Blood Pressure -- drug effects
- Capillaries -- drug effects
- Cell Count
- Cyclic GMP -- metabolism
- Disease Models, Animal
- Endothelial Growth Factors -- metabolism
- Femoral Artery -- physiopathology
- Hindlimb -- blood supply
- Ischemia -- physiopathology
- Lymphokines -- metabolism
- Male
- Mice
- Mice, Knockout
- Neovascularization, Physiologic -- drug effects
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase -- metabolism
- Nitric Oxide Synthase Type II
- Nitric Oxide Synthase Type III
- Receptor, Bradykinin B2
- Receptors, Bradykinin -- deficiency
- Signal Transduction -- drug effects
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.